Novo Holdings, a leading global healthcare and life sciences investor, announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd., a China-based contract development and manufacturing organisation (CDMO) specialising in advanced wound care products. GL Capital, one of China's leading health…
Labcorp a global leader of innovative and comprehensive laboratory services, announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed. The ac…
Invagen Pharmaceuticals Inc, a wholly owned subsidiary of Cipla Limited announced that it has entered into a strategic partnership with Qilu Pharmaceutical Co., Ltd. (hereinafter referred to as Qilu), for the exclusive licensing and supply of QL2107, a biosimilar to Keytruda® (pembrolizumab), for the United States As…
Medtronic, a global leader in healthcare technology, announced a strategic partnership with Cornerstone Robotics, an innovative surgical robotics company committed to advancing minimally invasive surgery and improving access to the latest surgical care worldwide. The approximately $700 million investment includes righ…
Monash Health, the largest public health service in Victoria, Australia, has signed a Memorandum of Understanding (MoU) with Data4Life, an international nonprofit digital health organization funded by the Hasso Plattner Foundation. The announcement was made by Associate Professor Tam C. Nguyen, Director of Research &a…
Harvest Integrated Research Organization (HiRO), a full-service global clinical research organization (CRO), and Differentia Biotech Ltd. ("Differentia"), a pioneer in knowledge-empowered modeling and simulation for drug development, announced a Memorandum of Understanding (MOU) establishing a strategic collaboration …
Samsung Biologics announced a rights offering to raise an expected aggregate amount of KRW 3 trillion to fund investments in the company's three-dimensional, long-term growth strategy across capacity, portfolio, and geographic expansion. The company plans to allocate approximately KRW 2.71 trillion of the offering …
The Hong Kong Applied Science and Technology Research Institute (ASTRI) and Saint Francis University (SFU) have signed a Memorandum of Understanding (MoU) to establish a strategic partnership focused on advancing research and development in AI-enabled biomaterials and digital health technologies. The collaboration aim…
Rznomics Inc, a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Lilly Gateway Labs is a best-in-class innovation hub designed to empower biotechnology companies to advance groundbreaking science by…
Ipsen announced it has completed the acquisition of Kartos Therapeutics, a clinical-stage biopharmaceutical company adding late-stage MDM2 inhibitor navtemadlin in Phase III clinical development in myelofibrosis.
Page 4 of 42